Page last updated: 2024-08-18

pyrazolanthrone and Autoimmune Diseases

pyrazolanthrone has been researched along with Autoimmune Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dakhama, A; Domenico, J; Gelfand, EW; Joetham, A; Ohnishi, H; Okamoto, M; Schedel, M; Takeda, K1

Other Studies

1 other study(ies) available for pyrazolanthrone and Autoimmune Diseases

ArticleYear
Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation.
    The Journal of biological chemistry, 2012, May-18, Volume: 287, Issue:21

    Topics: Animals; Anthracenes; Asthma; Autoimmune Diseases; Cell Proliferation; Enzyme Activation; Female; Glucocorticoid-Induced TNFR-Related Protein; Immune Tolerance; Lung; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mice; Mice, Knockout; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; T-Lymphocytes, Regulatory

2012